id
stringlengths
15
19
document_id
stringlengths
15
19
passages
list
entities
list
events
list
coreferences
list
relations
list
split_0_train_4500
split_0_train_4500
[ { "id": "split_0_train_4500_passage", "type": "progene_text", "text": [ "In addition , small amino acid residues ( G and A ) were enriched at P7 and G at P8 ." ], "offsets": [ [ 0, 85 ] ] } ]
[]
[]
[]
[]
split_0_train_4501
split_0_train_4501
[ { "id": "split_0_train_4501_passage", "type": "progene_text", "text": [ "The primary anchors at P6 and P9 defining the phage - derived motif were present in most high - affinity I-Ag7 - binding peptides from IDDM candidate antigens but only in < or = 25 % of peptides that were low - affinity binders or failed to bind to I - Ag7 ." ], "offsets": [ [ 0, 258 ] ] } ]
[ { "id": "split_0_train_7090_entity", "type": "progene_text", "text": [ "I-Ag7" ], "offsets": [ [ 105, 110 ] ], "normalized": [] }, { "id": "split_0_train_7091_entity", "type": "progene_text", "text": [ "I - Ag7" ], "offsets": [ [ 249, 256 ] ], "normalized": [] } ]
[]
[]
[]
split_0_train_4502
split_0_train_4502
[ { "id": "split_0_train_4502_passage", "type": "progene_text", "text": [ "A comparison of these results with the proposed motifs for peptide binding to I-Ag7 validates the one we have previously described ." ], "offsets": [ [ 0, 132 ] ] } ]
[ { "id": "split_0_train_7092_entity", "type": "progene_text", "text": [ "I-Ag7" ], "offsets": [ [ 78, 83 ] ], "normalized": [] } ]
[]
[]
[]
split_0_train_4503
split_0_train_4503
[ { "id": "split_0_train_4503_passage", "type": "progene_text", "text": [ "A role for focal adhesion kinase in phenylephrine - induced hypertrophy of rat ventricular cardiomyocytes ." ], "offsets": [ [ 0, 107 ] ] } ]
[ { "id": "split_0_train_7093_entity", "type": "progene_text", "text": [ "focal adhesion kinase" ], "offsets": [ [ 11, 32 ] ], "normalized": [] } ]
[]
[]
[]
split_0_train_4504
split_0_train_4504
[ { "id": "split_0_train_4504_passage", "type": "progene_text", "text": [ "A variety of agonists including phenylephrine ( PE ) induce hypertrophy in neonatal ventricular cardiomyocytes ." ], "offsets": [ [ 0, 112 ] ] } ]
[]
[]
[]
[]
split_0_train_4505
split_0_train_4505
[ { "id": "split_0_train_4505_passage", "type": "progene_text", "text": [ "Here we report that signals provided by extracellular matrix proteins ( ECM ) augment the PE - induced hypertrophic response of cardiomyocytes and provide evidence that ECM - dependent signaling is mediated in part by the protein tyrosine kinase , focal adhesion kinase ( FAK ) ." ], "offsets": [ [ 0, 279 ] ] } ]
[ { "id": "split_0_train_7094_entity", "type": "progene_text", "text": [ "protein tyrosine kinase" ], "offsets": [ [ 222, 245 ] ], "normalized": [] }, { "id": "split_0_train_7095_entity", "type": "progene_text", "text": [ "focal adhesion kinase" ], "offsets": [ [ 248, 269 ] ], "normalized": [] }, { "id": "split_0_train_7096_entity", "type": "progene_text", "text": [ "FAK" ], "offsets": [ [ 272, 275 ] ], "normalized": [] } ]
[]
[]
[]
split_0_train_4506
split_0_train_4506
[ { "id": "split_0_train_4506_passage", "type": "progene_text", "text": [ "Addition of PE to cultured neonatal cardiomyocytes stimulated sarcomeric organization , increased cell size , and induced atrial natriuretic factor in cardiomyocytes plated on the ECM protein laminin or fibronectin ." ], "offsets": [ [ 0, 216 ] ] } ]
[ { "id": "split_0_train_7097_entity", "type": "progene_text", "text": [ "atrial natriuretic factor" ], "offsets": [ [ 122, 147 ] ], "normalized": [] }, { "id": "split_0_train_7098_entity", "type": "progene_text", "text": [ "laminin" ], "offsets": [ [ 192, 199 ] ], "normalized": [] }, { "id": "split_0_train_7099_entity", "type": "progene_text", "text": [ "fibronectin" ], "offsets": [ [ 203, 214 ] ], "normalized": [] } ]
[]
[]
[]
split_0_train_4507
split_0_train_4507
[ { "id": "split_0_train_4507_passage", "type": "progene_text", "text": [ "In contrast , cardiomyocytes plated on the non - adhesive substrate gelatin exhibited a reduced capacity to undergo these PE - stimulated hypertrophic changes ." ], "offsets": [ [ 0, 160 ] ] } ]
[]
[]
[]
[]
split_0_train_4508
split_0_train_4508
[ { "id": "split_0_train_4508_passage", "type": "progene_text", "text": [ "In cardiomyocytes cultured on ECM , PE stimulated a rapid increase in tyrosine phosphorylation of focal adhesion proteins including FAK , paxillin , and p130 Crk - associated substrate and subsequent formation of peripheral focal complexes ." ], "offsets": [ [ 0, 241 ] ] } ]
[ { "id": "split_0_train_7100_entity", "type": "progene_text", "text": [ "FAK" ], "offsets": [ [ 132, 135 ] ], "normalized": [] }, { "id": "split_0_train_7101_entity", "type": "progene_text", "text": [ "paxillin" ], "offsets": [ [ 138, 146 ] ], "normalized": [] }, { "id": "split_0_train_7102_entity", "type": "progene_text", "text": [ "p130 Crk - associated substrate" ], "offsets": [ [ 153, 184 ] ], "normalized": [] } ]
[]
[]
[]
split_0_train_4509
split_0_train_4509
[ { "id": "split_0_train_4509_passage", "type": "progene_text", "text": [ "Inhibition of the PE - induced hypertrophic response by genistein and herbimycin-A indicated a requirement for protein tyrosine kinases in PE signaling ." ], "offsets": [ [ 0, 153 ] ] } ]
[ { "id": "split_0_train_7103_entity", "type": "progene_text", "text": [ "protein tyrosine kinases" ], "offsets": [ [ 111, 135 ] ], "normalized": [] } ]
[]
[]
[]
split_0_train_4510
split_0_train_4510
[ { "id": "split_0_train_4510_passage", "type": "progene_text", "text": [ "To determine whether activation of FAK is required for PE - induced hypertrophy , a dominant - interfering mutant form of FAK , termed FRNK ( FAK - related non - kinase ) , was ectopically expressed in cardiomyocytes using a replication - defective adenovirus expression system ." ], "offsets": [ [ 0, 279 ] ] } ]
[ { "id": "split_0_train_7104_entity", "type": "progene_text", "text": [ "FAK" ], "offsets": [ [ 35, 38 ] ], "normalized": [] }, { "id": "split_0_train_7105_entity", "type": "progene_text", "text": [ "FAK" ], "offsets": [ [ 122, 125 ] ], "normalized": [] }, { "id": "split_0_train_7106_entity", "type": "progene_text", "text": [ "FRNK" ], "offsets": [ [ 135, 139 ] ], "normalized": [] }, { "id": "split_0_train_7107_entity", "type": "progene_text", "text": [ "FAK - related non - kinase" ], "offsets": [ [ 142, 168 ] ], "normalized": [] } ]
[]
[]
[]
split_0_train_4511
split_0_train_4511
[ { "id": "split_0_train_4511_passage", "type": "progene_text", "text": [ "FRNK expression attenuated PE - stimulated hypertrophy as assessed by cell size , sarcomeric organization , and induction of atrial natriuretic factor ." ], "offsets": [ [ 0, 152 ] ] } ]
[ { "id": "split_0_train_7108_entity", "type": "progene_text", "text": [ "FRNK" ], "offsets": [ [ 0, 4 ] ], "normalized": [] }, { "id": "split_0_train_7109_entity", "type": "progene_text", "text": [ "atrial natriuretic factor" ], "offsets": [ [ 125, 150 ] ], "normalized": [] } ]
[]
[]
[]
split_0_train_4512
split_0_train_4512
[ { "id": "split_0_train_4512_passage", "type": "progene_text", "text": [ "These data indicate that the signal transduction pathways leading to cardiomyocyte hypertrophy are strongly influenced by and/or dependent upon an integrin - mediated signaling process requiring FAK ." ], "offsets": [ [ 0, 200 ] ] } ]
[ { "id": "split_0_train_7110_entity", "type": "progene_text", "text": [ "integrin" ], "offsets": [ [ 147, 155 ] ], "normalized": [] }, { "id": "split_0_train_7111_entity", "type": "progene_text", "text": [ "FAK" ], "offsets": [ [ 195, 198 ] ], "normalized": [] } ]
[]
[]
[]
split_0_train_4513
split_0_train_4513
[ { "id": "split_0_train_4513_passage", "type": "progene_text", "text": [ "Structural basis for the network of functional cooperativities in cytochrome c(3 ) from Desulfovibrio gigas : solution structures of the oxidised and reduced states ." ], "offsets": [ [ 0, 166 ] ] } ]
[ { "id": "split_0_train_7112_entity", "type": "progene_text", "text": [ "cytochrome c(3 )" ], "offsets": [ [ 66, 82 ] ], "normalized": [] } ]
[]
[]
[]
split_0_train_4514
split_0_train_4514
[ { "id": "split_0_train_4514_passage", "type": "progene_text", "text": [ "Cytochrome c(3) is a 14 kDa tetrahaem protein that plays a central role in the bioenergetic metabolism of Desulfovibrio spp. This involves an energy transduction mechanism made possible by a complex network of functional cooperativities between redox and redox / protolytic centres ( the redox - Bohr effect ) , which enables cytochrome c(3) to work as a proton activator ." ], "offsets": [ [ 0, 373 ] ] } ]
[ { "id": "split_0_train_7113_entity", "type": "progene_text", "text": [ "Cytochrome c(3)" ], "offsets": [ [ 0, 15 ] ], "normalized": [] }, { "id": "split_0_train_7114_entity", "type": "progene_text", "text": [ "cytochrome c(3)" ], "offsets": [ [ 326, 341 ] ], "normalized": [] } ]
[]
[]
[]
split_0_train_4515
split_0_train_4515
[ { "id": "split_0_train_4515_passage", "type": "progene_text", "text": [ "The three - dimensional structures of the oxidised and reduced Desulfovibrio gigas cytochrome c(3) in solution were solved using 2D ( 1 ) H-NMR data ." ], "offsets": [ [ 0, 150 ] ] } ]
[ { "id": "split_0_train_7115_entity", "type": "progene_text", "text": [ "cytochrome c(3)" ], "offsets": [ [ 83, 98 ] ], "normalized": [] } ]
[]
[]
[]
split_0_train_4516
split_0_train_4516
[ { "id": "split_0_train_4516_passage", "type": "progene_text", "text": [ "The reduced protein structures were calculated using INDYANA , an extended version of DYANA that allows automatic calibration of NOE data ." ], "offsets": [ [ 0, 139 ] ] } ]
[]
[]
[]
[]
split_0_train_4517
split_0_train_4517
[ { "id": "split_0_train_4517_passage", "type": "progene_text", "text": [ "The oxidised protein structure , which includes four paramagnetic centres , was solved using the program PARADYANA , which also includes the structural paramagnetic parameters ." ], "offsets": [ [ 0, 177 ] ] } ]
[]
[]
[]
[]
split_0_train_4518
split_0_train_4518
[ { "id": "split_0_train_4518_passage", "type": "progene_text", "text": [ "In this case , initial structures were used to correct the upper and lower volume restraints for paramagnetic leakage , and angle restraints derived from ( 13 ) C Fermi contact shifts of haem moiety substituents were used for the axial histidine ligands ." ], "offsets": [ [ 0, 255 ] ] } ]
[]
[]
[]
[]
split_0_train_4519
split_0_train_4519
[ { "id": "split_0_train_4519_passage", "type": "progene_text", "text": [ "Despite the reduction of the NOE intensities by paramagnetic relaxation , the final family of structures is of similar precision and accuracy to that obtained for the reduced form ." ], "offsets": [ [ 0, 181 ] ] } ]
[]
[]
[]
[]
split_0_train_4520
split_0_train_4520
[ { "id": "split_0_train_4520_passage", "type": "progene_text", "text": [ "Comparison of the two structures shows that , although the global folds of the two families of structures are similar , significant localised differences occur upon change of redox state , some of which could not be detected by comparison with the X - ray structure of the oxidised state : ( 1 ) there is a redox - linked concerted rearrangement of Lys80 and Lys90 that results in the stabilisation of haem moieties II and III when both molecules are oxidised or both are reduced , in agreement with the previously measured positive redox cooperativity between these two haem moieties ." ], "offsets": [ [ 0, 586 ] ] } ]
[]
[]
[]
[]
split_0_train_4521
split_0_train_4521
[ { "id": "split_0_train_4521_passage", "type": "progene_text", "text": [ "This cooperativity regulates electron transfer , enabling a two - electron step adapted to the function of cytochromes c(3) as the coupling partner of hydrogenase ; and ( 2 ) the movement of haem I propionate 13 towards the interior of the protein upon reduction explains the positive redox - Bohr effect , establishing the structural basis for the redox - linked proton activation mechanism necessary for energy conservation , driving ATP synthesis ." ], "offsets": [ [ 0, 451 ] ] } ]
[ { "id": "split_0_train_7116_entity", "type": "progene_text", "text": [ "cytochromes c(3)" ], "offsets": [ [ 107, 123 ] ], "normalized": [] }, { "id": "split_0_train_7117_entity", "type": "progene_text", "text": [ "hydrogenase" ], "offsets": [ [ 151, 162 ] ], "normalized": [] } ]
[]
[]
[]
split_0_train_4522
split_0_train_4522
[ { "id": "split_0_train_4522_passage", "type": "progene_text", "text": [ "The muscle mitogen - activated protein kinase is altered in sporadic inclusion body myositis ." ], "offsets": [ [ 0, 94 ] ] } ]
[ { "id": "split_0_train_7118_entity", "type": "progene_text", "text": [ "mitogen - activated protein kinase" ], "offsets": [ [ 11, 45 ] ], "normalized": [] } ]
[]
[]
[]
split_0_train_4523
split_0_train_4523
[ { "id": "split_0_train_4523_passage", "type": "progene_text", "text": [ "OBJECTIVE :" ], "offsets": [ [ 0, 11 ] ] } ]
[]
[]
[]
[]
split_0_train_4524
split_0_train_4524
[ { "id": "split_0_train_4524_passage", "type": "progene_text", "text": [ "To examine the origin of hyperphosphorylated proteins within the vacuolated myofibers in sporadic inclusion body myositis (s-IBM ) and search for dysregulated intracellular protein phosphorylation ." ], "offsets": [ [ 0, 198 ] ] } ]
[]
[]
[]
[]
split_0_train_4525
split_0_train_4525
[ { "id": "split_0_train_4525_passage", "type": "progene_text", "text": [ "BACKGROUND :" ], "offsets": [ [ 0, 12 ] ] } ]
[]
[]
[]
[]
split_0_train_4526
split_0_train_4526
[ { "id": "split_0_train_4526_passage", "type": "progene_text", "text": [ "s-IBM is morphologically characterized by primary endomysial inflammation and vacuolated myofibers containing tubulofilaments that originate from cytoskeletal proteins ." ], "offsets": [ [ 0, 169 ] ] } ]
[]
[]
[]
[]
split_0_train_4527
split_0_train_4527
[ { "id": "split_0_train_4527_passage", "type": "progene_text", "text": [ "Mitogen - activated protein kinases ( MAPKs ) play a role in regulating phosphorylation and maintaining the stability of the cytoskeletal architecture ." ], "offsets": [ [ 0, 152 ] ] } ]
[ { "id": "split_0_train_7119_entity", "type": "progene_text", "text": [ "Mitogen - activated protein kinases" ], "offsets": [ [ 0, 35 ] ], "normalized": [] }, { "id": "split_0_train_7120_entity", "type": "progene_text", "text": [ "MAPKs" ], "offsets": [ [ 38, 43 ] ], "normalized": [] } ]
[]
[]
[]
split_0_train_4528
split_0_train_4528
[ { "id": "split_0_train_4528_passage", "type": "progene_text", "text": [ "METHODS :" ], "offsets": [ [ 0, 9 ] ] } ]
[]
[]
[]
[]
split_0_train_4529
split_0_train_4529
[ { "id": "split_0_train_4529_passage", "type": "progene_text", "text": [ "Muscle biopsies from seven patients with s-IBM and 15 controls were examined for the expression of the active components of the various MAPKs , including p44 / 42MAPK , p38MAPK , p46JNK1 , p54JNK2 , and p54JNK3 , using immunocytochemistry and Western blot analysis ." ], "offsets": [ [ 0, 266 ] ] } ]
[ { "id": "split_0_train_7121_entity", "type": "progene_text", "text": [ "MAPKs" ], "offsets": [ [ 136, 141 ] ], "normalized": [] }, { "id": "split_0_train_7122_entity", "type": "progene_text", "text": [ "p44 / 42MAPK" ], "offsets": [ [ 154, 166 ] ], "normalized": [] }, { "id": "split_0_train_7123_entity", "type": "progene_text", "text": [ "p38MAPK" ], "offsets": [ [ 169, 176 ] ], "normalized": [] }, { "id": "split_0_train_7124_entity", "type": "progene_text", "text": [ "p46JNK1" ], "offsets": [ [ 179, 186 ] ], "normalized": [] }, { "id": "split_0_train_7125_entity", "type": "progene_text", "text": [ "p54JNK2" ], "offsets": [ [ 189, 196 ] ], "normalized": [] }, { "id": "split_0_train_7126_entity", "type": "progene_text", "text": [ "p54JNK3" ], "offsets": [ [ 203, 210 ] ], "normalized": [] } ]
[]
[]
[]
split_0_train_4530
split_0_train_4530
[ { "id": "split_0_train_4530_passage", "type": "progene_text", "text": [ "The expression of selected phosphorylated components was also examined in the same specimens ." ], "offsets": [ [ 0, 94 ] ] } ]
[]
[]
[]
[]
split_0_train_4531
split_0_train_4531
[ { "id": "split_0_train_4531_passage", "type": "progene_text", "text": [ "RESULTS :" ], "offsets": [ [ 0, 9 ] ] } ]
[]
[]
[]
[]
split_0_train_4532
split_0_train_4532
[ { "id": "split_0_train_4532_passage", "type": "progene_text", "text": [ "In s-IBM , but not the disease controls , the vacuolated muscle fibers express active p42MAPK but not JNK or p38MAPK ." ], "offsets": [ [ 0, 118 ] ] } ]
[ { "id": "split_0_train_7127_entity", "type": "progene_text", "text": [ "p42MAPK" ], "offsets": [ [ 86, 93 ] ], "normalized": [] }, { "id": "split_0_train_7128_entity", "type": "progene_text", "text": [ "JNK" ], "offsets": [ [ 102, 105 ] ], "normalized": [] }, { "id": "split_0_train_7129_entity", "type": "progene_text", "text": [ "p38MAPK" ], "offsets": [ [ 109, 116 ] ], "normalized": [] } ]
[]
[]
[]
split_0_train_4533
split_0_train_4533
[ { "id": "split_0_train_4533_passage", "type": "progene_text", "text": [ "Western blots of cell lysates confirmed the hyperexpression of p42MAPK and demonstrated a novel 35 kD phosphoprotein ." ], "offsets": [ [ 0, 118 ] ] } ]
[ { "id": "split_0_train_7130_entity", "type": "progene_text", "text": [ "p42MAPK" ], "offsets": [ [ 63, 70 ] ], "normalized": [] } ]
[]
[]
[]
split_0_train_4534
split_0_train_4534
[ { "id": "split_0_train_4534_passage", "type": "progene_text", "text": [ "Antibodies against phosphoepitopes of the 35 kD protein preferentially immunostained antigens within the vacuolated muscle fibers of s-IBM but not disease controls ." ], "offsets": [ [ 0, 165 ] ] } ]
[]
[]
[]
[]
split_0_train_4535
split_0_train_4535
[ { "id": "split_0_train_4535_passage", "type": "progene_text", "text": [ "CONCLUSION :" ], "offsets": [ [ 0, 12 ] ] } ]
[]
[]
[]
[]
split_0_train_4536
split_0_train_4536
[ { "id": "split_0_train_4536_passage", "type": "progene_text", "text": [ "In s-IBM , there is increased p42MAPK activation and abnormal intracellular protein phosphorylation with selective accumulation of a 35 kD phosphoprotein within the vacuolated fibers ." ], "offsets": [ [ 0, 184 ] ] } ]
[ { "id": "split_0_train_7131_entity", "type": "progene_text", "text": [ "p42MAPK" ], "offsets": [ [ 30, 37 ] ], "normalized": [] } ]
[]
[]
[]
split_0_train_4537
split_0_train_4537
[ { "id": "split_0_train_4537_passage", "type": "progene_text", "text": [ "Although the hyperexpression of 35kD protein may represent cytoskeletal by - products due to heightened p42MAPK activation , its abundant expression only in s-IBM implies that hyperphosphorylated myofibrillar proteins may be involved in the primary disease process ." ], "offsets": [ [ 0, 266 ] ] } ]
[ { "id": "split_0_train_7132_entity", "type": "progene_text", "text": [ "p42MAPK" ], "offsets": [ [ 104, 111 ] ], "normalized": [] } ]
[]
[]
[]
split_0_train_4538
split_0_train_4538
[ { "id": "split_0_train_4538_passage", "type": "progene_text", "text": [ "Mechanism of atherosclerotic calcification ." ], "offsets": [ [ 0, 44 ] ] } ]
[]
[]
[]
[]
split_0_train_4539
split_0_train_4539
[ { "id": "split_0_train_4539_passage", "type": "progene_text", "text": [ "Calcification is almost invariably associated with atherosclerotic plaque lesions ." ], "offsets": [ [ 0, 83 ] ] } ]
[]
[]
[]
[]
split_0_train_4540
split_0_train_4540
[ { "id": "split_0_train_4540_passage", "type": "progene_text", "text": [ "Recent data suggest that plaque calcification is an active , regulated process similar to osteogenesis ." ], "offsets": [ [ 0, 104 ] ] } ]
[]
[]
[]
[]
split_0_train_4541
split_0_train_4541
[ { "id": "split_0_train_4541_passage", "type": "progene_text", "text": [ "In order to clarify the mechanism of plaque calcification , we developed an in vitro model of vascular calcification by utilizing bovine vascular smooth muscle cells ( BVSMCs ) ." ], "offsets": [ [ 0, 178 ] ] } ]
[]
[]
[]
[]
split_0_train_4542
split_0_train_4542
[ { "id": "split_0_train_4542_passage", "type": "progene_text", "text": [ "This model is useful in that diffuse and massive calcification can be induced within 2 weeks and thereby biochemical analyses of vascular calcification can be performed ." ], "offsets": [ [ 0, 170 ] ] } ]
[]
[]
[]
[]
split_0_train_4543
split_0_train_4543
[ { "id": "split_0_train_4543_passage", "type": "progene_text", "text": [ "We have analyzed several aspects of vascular calcification by using this model and demonstrated as follows : 1 ) in vitro calcification of BVSMCs is regulated by calciotropic hormones and BVSMCs are equipped with a unique autocrine and/or paracrine system regulating calcium metabolism ." ], "offsets": [ [ 0, 287 ] ] } ]
[]
[]
[]
[]
split_0_train_4544
split_0_train_4544
[ { "id": "split_0_train_4544_passage", "type": "progene_text", "text": [ "2) Sodium - dependent phosphate cotransport plays a crucial role in BVSMC calcification as well as in mineralization of skeletal tissues ." ], "offsets": [ [ 0, 138 ] ] } ]
[]
[]
[]
[]
split_0_train_4545
split_0_train_4545
[ { "id": "split_0_train_4545_passage", "type": "progene_text", "text": [ "3) BVSMCs acquire osteoblastic phenotype under certain conditions ." ], "offsets": [ [ 0, 67 ] ] } ]
[]
[]
[]
[]
split_0_train_4546
split_0_train_4546
[ { "id": "split_0_train_4546_passage", "type": "progene_text", "text": [ "Finally , we discuss the roles of macrophages in the development of atherosclerotic calcification ." ], "offsets": [ [ 0, 99 ] ] } ]
[]
[]
[]
[]
split_0_train_4547
split_0_train_4547
[ { "id": "split_0_train_4547_passage", "type": "progene_text", "text": [ "Interferon - gamma ( IFN-gamma ) induces gene expression of 25-hydrovitamin D-1 alpha-hydroxylase ( 1 alpha OHase ) and its activity in macrophages ." ], "offsets": [ [ 0, 149 ] ] } ]
[ { "id": "split_0_train_7133_entity", "type": "progene_text", "text": [ "Interferon - gamma" ], "offsets": [ [ 0, 18 ] ], "normalized": [] }, { "id": "split_0_train_7134_entity", "type": "progene_text", "text": [ "IFN-gamma" ], "offsets": [ [ 21, 30 ] ], "normalized": [] }, { "id": "split_0_train_7135_entity", "type": "progene_text", "text": [ "25-hydrovitamin D-1 alpha-hydroxylase" ], "offsets": [ [ 60, 97 ] ], "normalized": [] }, { "id": "split_0_train_7136_entity", "type": "progene_text", "text": [ "1 alpha OHase" ], "offsets": [ [ 100, 113 ] ], "normalized": [] } ]
[]
[]
[]
split_0_train_4548
split_0_train_4548
[ { "id": "split_0_train_4548_passage", "type": "progene_text", "text": [ "Since 1 alpha OHase can locally convert 25-hydroxyvitamin D into 1 alpha , 25-dihydroxyvitamin D ( 1,25(OH)2D ) , an active metabolite of vitamin D , it is suggested that local production of 1,25(OH)2D by macrophages may promote atherosclerotic calcification ." ], "offsets": [ [ 0, 260 ] ] } ]
[ { "id": "split_0_train_7137_entity", "type": "progene_text", "text": [ "1 alpha OHase" ], "offsets": [ [ 6, 19 ] ], "normalized": [] } ]
[]
[]
[]
split_0_train_4549
split_0_train_4549
[ { "id": "split_0_train_4549_passage", "type": "progene_text", "text": [ "Moreover , macrophages may be involved in the phenotypic changes of vascular smooth muscle cells ( VSMCs ) to acquire calcifying capacity ." ], "offsets": [ [ 0, 139 ] ] } ]
[]
[]
[]
[]
split_0_train_4550
split_0_train_4550
[ { "id": "split_0_train_4550_passage", "type": "progene_text", "text": [ "Therefore , the phenotypic changes of VSMCs in atherosclerotic plaque may contribute to the development of atherosclerotic calcification ." ], "offsets": [ [ 0, 138 ] ] } ]
[]
[]
[]
[]
split_0_train_4551
split_0_train_4551
[ { "id": "split_0_train_4551_passage", "type": "progene_text", "text": [ "A mutation in the Corynebacterium glutamicum ltsA gene causes susceptibility to lysozyme , temperature - sensitive growth , and L-glutamate production ." ], "offsets": [ [ 0, 152 ] ] } ]
[ { "id": "split_0_train_7138_entity", "type": "progene_text", "text": [ "ltsA" ], "offsets": [ [ 45, 49 ] ], "normalized": [] }, { "id": "split_0_train_7139_entity", "type": "progene_text", "text": [ "lysozyme" ], "offsets": [ [ 80, 88 ] ], "normalized": [] } ]
[]
[]
[]
split_0_train_4552
split_0_train_4552
[ { "id": "split_0_train_4552_passage", "type": "progene_text", "text": [ "The Corynebacterium glutamicum mutant KY9714 , originally isolated as a lysozyme - sensitive mutant , does not grow at 37 degrees C ." ], "offsets": [ [ 0, 133 ] ] } ]
[ { "id": "split_0_train_7140_entity", "type": "progene_text", "text": [ "lysozyme" ], "offsets": [ [ 72, 80 ] ], "normalized": [] } ]
[]
[]
[]
split_0_train_4553
split_0_train_4553
[ { "id": "split_0_train_4553_passage", "type": "progene_text", "text": [ "Complementation tests and DNA sequencing analysis revealed that a mutation in a single gene of 1 , 920 bp , ltsA ( lysozyme and temperature sensitive ) , was responsible for its lysozyme sensitivity and temperature sensitivity ." ], "offsets": [ [ 0, 228 ] ] } ]
[ { "id": "split_0_train_7141_entity", "type": "progene_text", "text": [ "ltsA" ], "offsets": [ [ 108, 112 ] ], "normalized": [] }, { "id": "split_0_train_7142_entity", "type": "progene_text", "text": [ "lysozyme and temperature sensitive" ], "offsets": [ [ 115, 149 ] ], "normalized": [] }, { "id": "split_0_train_7143_entity", "type": "progene_text", "text": [ "lysozyme" ], "offsets": [ [ 178, 186 ] ], "normalized": [] } ]
[]
[]
[]
split_0_train_4554
split_0_train_4554
[ { "id": "split_0_train_4554_passage", "type": "progene_text", "text": [ "The ltsA gene encodes a protein homologous to the glutamine - dependent asparagine synthetases of various organisms , but it could not rescue the asparagine auxotrophy of an Escherichia coli asnA asnB double mutant ." ], "offsets": [ [ 0, 216 ] ] } ]
[ { "id": "split_0_train_7144_entity", "type": "progene_text", "text": [ "ltsA" ], "offsets": [ [ 4, 8 ] ], "normalized": [] }, { "id": "split_0_train_7145_entity", "type": "progene_text", "text": [ "glutamine - dependent asparagine synthetases" ], "offsets": [ [ 50, 94 ] ], "normalized": [] }, { "id": "split_0_train_7146_entity", "type": "progene_text", "text": [ "asnA" ], "offsets": [ [ 191, 195 ] ], "normalized": [] }, { "id": "split_0_train_7147_entity", "type": "progene_text", "text": [ "asnB" ], "offsets": [ [ 196, 200 ] ], "normalized": [] } ]
[]
[]
[]
split_0_train_4555
split_0_train_4555
[ { "id": "split_0_train_4555_passage", "type": "progene_text", "text": [ "Replacement of the N-terminal Cys residue ( which is conserved in glutamine - dependent amidotransferases and is essential for enzyme activity ) by an Ala residue resulted in the loss of complementation in C. glutamicum ." ], "offsets": [ [ 0, 221 ] ] } ]
[ { "id": "split_0_train_7148_entity", "type": "progene_text", "text": [ "glutamine - dependent amidotransferases" ], "offsets": [ [ 66, 105 ] ], "normalized": [] } ]
[]
[]
[]
split_0_train_4556
split_0_train_4556
[ { "id": "split_0_train_4556_passage", "type": "progene_text", "text": [ "The mutant ltsA gene has an amber mutation , and the disruption of the ltsA gene caused lysozyme and temperature sensitivity similar to that in the KY9714 mutant ." ], "offsets": [ [ 0, 163 ] ] } ]
[ { "id": "split_0_train_7149_entity", "type": "progene_text", "text": [ "ltsA" ], "offsets": [ [ 11, 15 ] ], "normalized": [] }, { "id": "split_0_train_7150_entity", "type": "progene_text", "text": [ "ltsA" ], "offsets": [ [ 71, 75 ] ], "normalized": [] } ]
[]
[]
[]
split_0_train_4557
split_0_train_4557
[ { "id": "split_0_train_4557_passage", "type": "progene_text", "text": [ "L-Glutamate production was induced by elevating growth temperature in the disruptant ." ], "offsets": [ [ 0, 86 ] ] } ]
[]
[]
[]
[]
split_0_train_4558
split_0_train_4558
[ { "id": "split_0_train_4558_passage", "type": "progene_text", "text": [ "These results indicate that the ltsA gene encodes a novel glutamine - dependent amidotransferase that is involved in the mechanisms of formation of rigid cell wall structure and in the L-glutamate production of C. glutamicum ." ], "offsets": [ [ 0, 226 ] ] } ]
[ { "id": "split_0_train_7151_entity", "type": "progene_text", "text": [ "ltsA" ], "offsets": [ [ 32, 36 ] ], "normalized": [] }, { "id": "split_0_train_7152_entity", "type": "progene_text", "text": [ "glutamine - dependent amidotransferase" ], "offsets": [ [ 58, 96 ] ], "normalized": [] } ]
[]
[]
[]
split_0_train_4559
split_0_train_4559
[ { "id": "split_0_train_4559_passage", "type": "progene_text", "text": [ "Bivalent sequential binding model of a Bacillus thuringiensis toxin to gypsy moth aminopeptidase N receptor ." ], "offsets": [ [ 0, 109 ] ] } ]
[ { "id": "split_0_train_7153_entity", "type": "progene_text", "text": [ "aminopeptidase N" ], "offsets": [ [ 82, 98 ] ], "normalized": [] } ]
[]
[]
[]
split_0_train_4560
split_0_train_4560
[ { "id": "split_0_train_4560_passage", "type": "progene_text", "text": [ "Specificity for target insects of Bacillus thuringiensis insecticidal Cry toxins is largely determined by toxin affinity for insect midgut receptors ." ], "offsets": [ [ 0, 150 ] ] } ]
[ { "id": "split_0_train_7154_entity", "type": "progene_text", "text": [ "Cry" ], "offsets": [ [ 70, 73 ] ], "normalized": [] } ]
[]
[]
[]
split_0_train_4561
split_0_train_4561
[ { "id": "split_0_train_4561_passage", "type": "progene_text", "text": [ "The mode of binding for one such toxin - receptor complex was investigated by extensive toxin mutagenesis , followed by real - time receptor binding analysis using an optical biosensor ( BIAcore ) ." ], "offsets": [ [ 0, 198 ] ] } ]
[]
[]
[]
[]
split_0_train_4562
split_0_train_4562
[ { "id": "split_0_train_4562_passage", "type": "progene_text", "text": [ "Wild - type Cry1Ac , a three - domain , lepidopteran - specific toxin , bound purified gypsy moth ( Lymantria dispar ) aminopeptidase N ( APN ) biphasically ." ], "offsets": [ [ 0, 158 ] ] } ]
[ { "id": "split_0_train_7155_entity", "type": "progene_text", "text": [ "Cry1Ac" ], "offsets": [ [ 12, 18 ] ], "normalized": [] }, { "id": "split_0_train_7156_entity", "type": "progene_text", "text": [ "aminopeptidase N" ], "offsets": [ [ 119, 135 ] ], "normalized": [] }, { "id": "split_0_train_7157_entity", "type": "progene_text", "text": [ "APN" ], "offsets": [ [ 138, 141 ] ], "normalized": [] } ]
[]
[]
[]
split_0_train_4563
split_0_train_4563
[ { "id": "split_0_train_4563_passage", "type": "progene_text", "text": [ "Site 1 displayed fast association and dissociation kinetics , while site 2 possessed slower kinetics , yet tighter affinity ." ], "offsets": [ [ 0, 125 ] ] } ]
[]
[]
[]
[]
split_0_train_4564
split_0_train_4564
[ { "id": "split_0_train_4564_passage", "type": "progene_text", "text": [ "We empirically determined that two Cry1Ac surface regions are involved in in vivo toxicity and APN binding ." ], "offsets": [ [ 0, 108 ] ] } ]
[ { "id": "split_0_train_7158_entity", "type": "progene_text", "text": [ "Cry1Ac" ], "offsets": [ [ 35, 41 ] ], "normalized": [] }, { "id": "split_0_train_7159_entity", "type": "progene_text", "text": [ "APN" ], "offsets": [ [ 95, 98 ] ], "normalized": [] } ]
[]
[]
[]
split_0_train_4565
split_0_train_4565
[ { "id": "split_0_train_4565_passage", "type": "progene_text", "text": [ "Mutations within domain III affected binding rates to APN site 1 , whereas mutations in domain II affected binding rates to APN site 2 ." ], "offsets": [ [ 0, 136 ] ] } ]
[ { "id": "split_0_train_7160_entity", "type": "progene_text", "text": [ "APN" ], "offsets": [ [ 54, 57 ] ], "normalized": [] }, { "id": "split_0_train_7161_entity", "type": "progene_text", "text": [ "APN" ], "offsets": [ [ 124, 127 ] ], "normalized": [] } ]
[]
[]
[]
split_0_train_4566
split_0_train_4566
[ { "id": "split_0_train_4566_passage", "type": "progene_text", "text": [ "Furthermore , domain III contact is completely inhibited in the presence of N - acetylgalactosamine , indicating loss of domain III binding eliminates all APN binding ." ], "offsets": [ [ 0, 168 ] ] } ]
[ { "id": "split_0_train_7162_entity", "type": "progene_text", "text": [ "APN" ], "offsets": [ [ 155, 158 ] ], "normalized": [] } ]
[]
[]
[]
split_0_train_4567
split_0_train_4567
[ { "id": "split_0_train_4567_passage", "type": "progene_text", "text": [ "Based upon these observations , the following model is proposed ." ], "offsets": [ [ 0, 65 ] ] } ]
[]
[]
[]
[]
split_0_train_4568
split_0_train_4568
[ { "id": "split_0_train_4568_passage", "type": "progene_text", "text": [ "A cavity in lectin - like domain III initiates docking through recognition of an N-acetylgalactosamine moiety on L. dispar APN ." ], "offsets": [ [ 0, 128 ] ] } ]
[ { "id": "split_0_train_7163_entity", "type": "progene_text", "text": [ "lectin" ], "offsets": [ [ 12, 18 ] ], "normalized": [] }, { "id": "split_0_train_7164_entity", "type": "progene_text", "text": [ "APN" ], "offsets": [ [ 123, 126 ] ], "normalized": [] } ]
[]
[]
[]
split_0_train_4569
split_0_train_4569
[ { "id": "split_0_train_4569_passage", "type": "progene_text", "text": [ "Following primary docking , a higher affinity domain II binding mechanism occurs , which is critical for insecticidal activity ." ], "offsets": [ [ 0, 128 ] ] } ]
[]
[]
[]
[]
split_0_train_4570
split_0_train_4570
[ { "id": "split_0_train_4570_passage", "type": "progene_text", "text": [ "Dual effect of IL-4 on resistance to systemic gram - negative infection and production of TNF-alpha ." ], "offsets": [ [ 0, 101 ] ] } ]
[ { "id": "split_0_train_7165_entity", "type": "progene_text", "text": [ "IL-4" ], "offsets": [ [ 15, 19 ] ], "normalized": [] }, { "id": "split_0_train_7166_entity", "type": "progene_text", "text": [ "TNF-alpha" ], "offsets": [ [ 90, 99 ] ], "normalized": [] } ]
[]
[]
[]
split_0_train_4571
split_0_train_4571
[ { "id": "split_0_train_4571_passage", "type": "progene_text", "text": [ "To determine the effect of interleukin 4 ( IL-4 ) administration in a live sepsis model characterised by high - level production of tumour necrosis factor a ( TNF-alpha ) , mice infected systemically with lethal or sublethal inocula of Pseudomonas aeruginosa were given the recombinant cytokine at different times before infection ." ], "offsets": [ [ 0, 332 ] ] } ]
[ { "id": "split_0_train_7167_entity", "type": "progene_text", "text": [ "interleukin 4" ], "offsets": [ [ 27, 40 ] ], "normalized": [] }, { "id": "split_0_train_7168_entity", "type": "progene_text", "text": [ "IL-4" ], "offsets": [ [ 43, 47 ] ], "normalized": [] }, { "id": "split_0_train_7169_entity", "type": "progene_text", "text": [ "tumour necrosis factor a" ], "offsets": [ [ 132, 156 ] ], "normalized": [] }, { "id": "split_0_train_7170_entity", "type": "progene_text", "text": [ "TNF-alpha" ], "offsets": [ [ 159, 168 ] ], "normalized": [] }, { "id": "split_0_train_7171_entity", "type": "progene_text", "text": [ "cytokine" ], "offsets": [ [ 286, 294 ] ], "normalized": [] } ]
[]
[]
[]
split_0_train_4572
split_0_train_4572
[ { "id": "split_0_train_4572_passage", "type": "progene_text", "text": [ "Improved survival and decreased TNF-alpha production were observed in lethally infected mice treated with the cytokine 1 day before challenge ." ], "offsets": [ [ 0, 143 ] ] } ]
[ { "id": "split_0_train_7172_entity", "type": "progene_text", "text": [ "TNF-alpha" ], "offsets": [ [ 32, 41 ] ], "normalized": [] }, { "id": "split_0_train_7173_entity", "type": "progene_text", "text": [ "cytokine" ], "offsets": [ [ 110, 118 ] ], "normalized": [] } ]
[]
[]
[]
split_0_train_4573
split_0_train_4573
[ { "id": "split_0_train_4573_passage", "type": "progene_text", "text": [ "In contrast , increased mortality and overproduction of TNF-alpha were observed in sublethally infected mice given IL-4 at the time of infection ." ], "offsets": [ [ 0, 146 ] ] } ]
[ { "id": "split_0_train_7174_entity", "type": "progene_text", "text": [ "TNF-alpha" ], "offsets": [ [ 56, 65 ] ], "normalized": [] }, { "id": "split_0_train_7175_entity", "type": "progene_text", "text": [ "IL-4" ], "offsets": [ [ 115, 119 ] ], "normalized": [] } ]
[]
[]
[]
split_0_train_4574
split_0_train_4574
[ { "id": "split_0_train_4574_passage", "type": "progene_text", "text": [ "Bradykinin B2 - receptor antagonism attenuates fatal cardiocirculatory breakdown induced by severe experimental pancreatitis ." ], "offsets": [ [ 0, 126 ] ] } ]
[ { "id": "split_0_train_7176_entity", "type": "progene_text", "text": [ "Bradykinin B2 - receptor" ], "offsets": [ [ 0, 24 ] ], "normalized": [] } ]
[]
[]
[]
split_0_train_4575
split_0_train_4575
[ { "id": "split_0_train_4575_passage", "type": "progene_text", "text": [ "OBJECTIVES :" ], "offsets": [ [ 0, 12 ] ] } ]
[]
[]
[]
[]
split_0_train_4576
split_0_train_4576
[ { "id": "split_0_train_4576_passage", "type": "progene_text", "text": [ "To investigate the impact of the long - acting bradykinin B2 receptor antagonist HOE 140 ( Icatibant ) on survival time in a model of severe porcine pancreatitis ." ], "offsets": [ [ 0, 163 ] ] } ]
[ { "id": "split_0_train_7177_entity", "type": "progene_text", "text": [ "bradykinin B2 receptor" ], "offsets": [ [ 47, 69 ] ], "normalized": [] } ]
[]
[]
[]
split_0_train_4577
split_0_train_4577
[ { "id": "split_0_train_4577_passage", "type": "progene_text", "text": [ "DESIGN :" ], "offsets": [ [ 0, 8 ] ] } ]
[]
[]
[]
[]
split_0_train_4578
split_0_train_4578
[ { "id": "split_0_train_4578_passage", "type": "progene_text", "text": [ "Randomized , controlled intervention trial ." ], "offsets": [ [ 0, 44 ] ] } ]
[]
[]
[]
[]
split_0_train_4579
split_0_train_4579
[ { "id": "split_0_train_4579_passage", "type": "progene_text", "text": [ "SUBJECTS :" ], "offsets": [ [ 0, 10 ] ] } ]
[]
[]
[]
[]
split_0_train_4580
split_0_train_4580
[ { "id": "split_0_train_4580_passage", "type": "progene_text", "text": [ "Thirty domestic pigs of either gender anesthetized by intravenous application of piritramide , midazolam , and pancuronium and mechanically ventilated ." ], "offsets": [ [ 0, 152 ] ] } ]
[]
[]
[]
[]
split_0_train_4581
split_0_train_4581
[ { "id": "split_0_train_4581_passage", "type": "progene_text", "text": [ "INTERVENTIONS :" ], "offsets": [ [ 0, 15 ] ] } ]
[]
[]
[]
[]
split_0_train_4582
split_0_train_4582
[ { "id": "split_0_train_4582_passage", "type": "progene_text", "text": [ "Pancreatitis was induced by an injection of sodium taurocholate ( 5 % , 1 mL / kg body weight [ BW ] ) and enterokinase ( 10 U / kg BW ) ." ], "offsets": [ [ 0, 138 ] ] } ]
[ { "id": "split_0_train_7178_entity", "type": "progene_text", "text": [ "enterokinase" ], "offsets": [ [ 107, 119 ] ], "normalized": [] } ]
[]
[]
[]
split_0_train_4583
split_0_train_4583
[ { "id": "split_0_train_4583_passage", "type": "progene_text", "text": [ "Control animals ( group 1 , n = 10 ) underwent the spontaneous course of the disease ." ], "offsets": [ [ 0, 86 ] ] } ]
[]
[]
[]
[]
split_0_train_4584
split_0_train_4584
[ { "id": "split_0_train_4584_passage", "type": "progene_text", "text": [ "In two treatment groups , Icatibant was administered either in a low ( 100 nmol / kg BW ; group 2 , n = 10 ) or in a high dosage ( 5000 nmol / kg BW ; group 3 , n = 10 ) ." ], "offsets": [ [ 0, 171 ] ] } ]
[]
[]
[]
[]
split_0_train_4585
split_0_train_4585
[ { "id": "split_0_train_4585_passage", "type": "progene_text", "text": [ "MEASUREMENTS AND MAIN RESULTS :" ], "offsets": [ [ 0, 31 ] ] } ]
[]
[]
[]
[]
split_0_train_4586
split_0_train_4586
[ { "id": "split_0_train_4586_passage", "type": "progene_text", "text": [ "Mean survival time was significantly prolonged by Icatibant ( controls , 6.6 hrs ; group 2 , 9.8 hrs ; p = .022 ; group 3 , 10.9 hrs ; p = .007 ) ." ], "offsets": [ [ 0, 147 ] ] } ]
[]
[]
[]
[]
split_0_train_4587
split_0_train_4587
[ { "id": "split_0_train_4587_passage", "type": "progene_text", "text": [ "Six hours postinduction , the decline of total peripheral resistance ( 52 % of baseline ) and cardiac index ( 92 % of baseline ) in controls was significantly improved by Icatibant , both in the low ( 16 % and 44 % ; p < .05 ) and high ( 6 % and 45 % ; p < .05 ) dosage ." ], "offsets": [ [ 0, 271 ] ] } ]
[]
[]
[]
[]
split_0_train_4588
split_0_train_4588
[ { "id": "split_0_train_4588_passage", "type": "progene_text", "text": [ "The concentrations of free , nonreceptor - bound kinin in plasma 6 hrs postinduction were significantly lower in controls than in groups 2 and 3 animals ( 111 + / - 50 vs. 208 +/- 40 and 237 + / - 52 fmol / mL , respectively ) ." ], "offsets": [ [ 0, 228 ] ] } ]
[ { "id": "split_0_train_7179_entity", "type": "progene_text", "text": [ "kinin" ], "offsets": [ [ 49, 54 ] ], "normalized": [] } ]
[]
[]
[]
split_0_train_4589
split_0_train_4589
[ { "id": "split_0_train_4589_passage", "type": "progene_text", "text": [ "Six hours postinduction , the pretreatment with Icatibant was associated with significantly higher plasma concentrations of phospholipase A2 ( controls , + 1194 % ; group 2 , + 2000 % ; group 3 , + 2285 % of baseline values ) and interleukin-1 receptor antagonist ( controls , 1900 + / - 800 ; group 2 , 3100 + / - 800 ; group 3 , 3600 + / - 800 pg / mL ) ." ], "offsets": [ [ 0, 357 ] ] } ]
[ { "id": "split_0_train_7180_entity", "type": "progene_text", "text": [ "phospholipase A2" ], "offsets": [ [ 124, 140 ] ], "normalized": [] }, { "id": "split_0_train_7181_entity", "type": "progene_text", "text": [ "interleukin-1 receptor antagonist" ], "offsets": [ [ 230, 263 ] ], "normalized": [] } ]
[]
[]
[]
split_0_train_4590
split_0_train_4590
[ { "id": "split_0_train_4590_passage", "type": "progene_text", "text": [ "In contrast , the increase of urinary trypsinogen activation peptides indicating local pancreatic damage ( 589 + / - 114 nmol / L in controls ) was substantially attenuated by pretreatment with Icatibant ( group 2 , 467 + / - 102 , NS ; 352+ / - 91 nmol / L in group 3 ; p = .022 vs. controls ) ." ], "offsets": [ [ 0, 296 ] ] } ]
[ { "id": "split_0_train_7182_entity", "type": "progene_text", "text": [ "trypsinogen" ], "offsets": [ [ 38, 49 ] ], "normalized": [] } ]
[]
[]
[]
split_0_train_4591
split_0_train_4591
[ { "id": "split_0_train_4591_passage", "type": "progene_text", "text": [ "Systemic inflammatory reactions , however , as quantified by C - reactive protein and the extracellularly discharged neutrophil cytosolic inhibitor leukocyte neutral proteinase inhibitor were not influenced by the bradykinin B2 - receptor antagonist ." ], "offsets": [ [ 0, 251 ] ] } ]
[ { "id": "split_0_train_7183_entity", "type": "progene_text", "text": [ "C - reactive protein" ], "offsets": [ [ 61, 81 ] ], "normalized": [] }, { "id": "split_0_train_7184_entity", "type": "progene_text", "text": [ "neutral proteinase" ], "offsets": [ [ 158, 176 ] ], "normalized": [] }, { "id": "split_0_train_7185_entity", "type": "progene_text", "text": [ "bradykinin B2 - receptor" ], "offsets": [ [ 214, 238 ] ], "normalized": [] } ]
[]
[]
[]
split_0_train_4592
split_0_train_4592
[ { "id": "split_0_train_4592_passage", "type": "progene_text", "text": [ "CONCLUSIONS :" ], "offsets": [ [ 0, 13 ] ] } ]
[]
[]
[]
[]
split_0_train_4593
split_0_train_4593
[ { "id": "split_0_train_4593_passage", "type": "progene_text", "text": [ "Pretreatment with the bradykinin B2 receptor antagonist Icatibant resulted in prolonged survival time and in delayed impairment of major macrocirculatory and pulmonary variables ." ], "offsets": [ [ 0, 179 ] ] } ]
[ { "id": "split_0_train_7186_entity", "type": "progene_text", "text": [ "bradykinin B2 receptor" ], "offsets": [ [ 22, 44 ] ], "normalized": [] } ]
[]
[]
[]
split_0_train_4594
split_0_train_4594
[ { "id": "split_0_train_4594_passage", "type": "progene_text", "text": [ "Icatibant resulted in elevated concentrations of free , circulating kinin ." ], "offsets": [ [ 0, 75 ] ] } ]
[ { "id": "split_0_train_7187_entity", "type": "progene_text", "text": [ "kinin" ], "offsets": [ [ 68, 73 ] ], "normalized": [] } ]
[]
[]
[]
split_0_train_4595
split_0_train_4595
[ { "id": "split_0_train_4595_passage", "type": "progene_text", "text": [ "This was associated with increased concentrations of phospholipase A2 and interleukin-1 receptor antagonist , suggesting that circulating kinins strengthen the activation of some mediator cascades , the association of which with the kinin metabolism requires further experimental clarification ." ], "offsets": [ [ 0, 295 ] ] } ]
[ { "id": "split_0_train_7188_entity", "type": "progene_text", "text": [ "phospholipase A2" ], "offsets": [ [ 53, 69 ] ], "normalized": [] }, { "id": "split_0_train_7189_entity", "type": "progene_text", "text": [ "interleukin-1 receptor antagonist" ], "offsets": [ [ 74, 107 ] ], "normalized": [] }, { "id": "split_0_train_7190_entity", "type": "progene_text", "text": [ "kinins" ], "offsets": [ [ 138, 144 ] ], "normalized": [] }, { "id": "split_0_train_7191_entity", "type": "progene_text", "text": [ "kinin" ], "offsets": [ [ 233, 238 ] ], "normalized": [] } ]
[]
[]
[]
split_0_train_4596
split_0_train_4596
[ { "id": "split_0_train_4596_passage", "type": "progene_text", "text": [ "Other variables indicating a systemic inflammatory response ( C - reactive protein , leukocyte neutral proteinase inhibitor ) remained unaffected by Icatibant ." ], "offsets": [ [ 0, 160 ] ] } ]
[ { "id": "split_0_train_7192_entity", "type": "progene_text", "text": [ "C - reactive protein" ], "offsets": [ [ 62, 82 ] ], "normalized": [] }, { "id": "split_0_train_7193_entity", "type": "progene_text", "text": [ "neutral proteinase" ], "offsets": [ [ 95, 113 ] ], "normalized": [] } ]
[]
[]
[]
split_0_train_4597
split_0_train_4597
[ { "id": "split_0_train_4597_passage", "type": "progene_text", "text": [ "Bradykinin antagonism distinctly ameliorated the local pancreatic damage , indicated by increased urinary concentrations of trypsinogen activation peptides ." ], "offsets": [ [ 0, 157 ] ] } ]
[ { "id": "split_0_train_7194_entity", "type": "progene_text", "text": [ "Bradykinin" ], "offsets": [ [ 0, 10 ] ], "normalized": [] }, { "id": "split_0_train_7195_entity", "type": "progene_text", "text": [ "trypsinogen" ], "offsets": [ [ 124, 135 ] ], "normalized": [] } ]
[]
[]
[]
split_0_train_4598
split_0_train_4598
[ { "id": "split_0_train_4598_passage", "type": "progene_text", "text": [ "It is concluded that the kinin metabolism plays an important role in the pathophysiology of systemic complications after severe experimental pancreatitis ." ], "offsets": [ [ 0, 155 ] ] } ]
[ { "id": "split_0_train_7196_entity", "type": "progene_text", "text": [ "kinin" ], "offsets": [ [ 25, 30 ] ], "normalized": [] } ]
[]
[]
[]
split_0_train_4599
split_0_train_4599
[ { "id": "split_0_train_4599_passage", "type": "progene_text", "text": [ "Genetic analysis of insulin - like growth factor II and HLA-G in pre - eclampsia ." ], "offsets": [ [ 0, 82 ] ] } ]
[ { "id": "split_0_train_7197_entity", "type": "progene_text", "text": [ "insulin - like growth factor II" ], "offsets": [ [ 20, 51 ] ], "normalized": [] }, { "id": "split_0_train_7198_entity", "type": "progene_text", "text": [ "HLA-G" ], "offsets": [ [ 56, 61 ] ], "normalized": [] } ]
[]
[]
[]